92 related articles for article (PubMed ID: 8099562)
1. [A study on the pharmacological action of phencyclidine].
Ohmori T
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):205-13. PubMed ID: 8099562
[TBL] [Abstract][Full Text] [Related]
2. Effect of phencyclidine on spontaneous and N-methyl-D-aspartate (NMDA)-induced efflux of dopamine from superfused slices of rat striatum.
Ohmori T; Koyama T; Nakamura F; Wang P; Yamashita I
Neuropharmacology; 1992 May; 31(5):461-7. PubMed ID: 1528397
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
4. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells.
Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF
Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729
[TBL] [Abstract][Full Text] [Related]
5. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
Jones SM; Snell LD; Johnson KM
J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic dopaminergic activity of phencyclidine in rat caudate.
Johnson SW; Haroldsen PE; Hoffer BJ; Freedman R
J Pharmacol Exp Ther; 1984 Apr; 229(1):321-32. PubMed ID: 6707946
[TBL] [Abstract][Full Text] [Related]
8. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
[TBL] [Abstract][Full Text] [Related]
10. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
Vickroy TW; Johnson KM
J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
[TBL] [Abstract][Full Text] [Related]
12. The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine.
Pechnick RN; Bresee CJ; Poland RE
Life Sci; 2006 Mar; 78(17):2006-11. PubMed ID: 16288927
[TBL] [Abstract][Full Text] [Related]
13. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
Klamer D; Zhang J; Engel JA; Svensson L
Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
[TBL] [Abstract][Full Text] [Related]
14. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
Nicholson KL; Jones HE; Balster RL
Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
[TBL] [Abstract][Full Text] [Related]
17. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
Jentsch JD; Wise A; Katz Z; Roth RH
Synapse; 1998 Jan; 28(1):21-6. PubMed ID: 9414014
[TBL] [Abstract][Full Text] [Related]
18. The effect of phencyclidine and DL-2-amino-5-phosphonovaleric acid on N-methyl-D-aspartic acid induced changes in extracellular concentration of dopamine and DOPAC in the rat neostriatum.
Marek P; Chapman CD; Howard S
Neuropharmacology; 1992 Feb; 31(2):123-7. PubMed ID: 1348111
[TBL] [Abstract][Full Text] [Related]
19. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
Shi WX; Zhang XX
J Pharmacol Exp Ther; 2003 May; 305(2):680-7. PubMed ID: 12606677
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
Bakshi VP; Geyer MA
J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
